Navigation Links
Journal Sleep: A short-term dose of zolpidem is an effective treatment for insomnia
Date:1/1/2008

WESTCHESTER, Ill. A study published in the January 1 issue of the journal SLEEP finds that zolpidem extended-release 12.5 mg, taken three to seven nights per week for up to six months, provided sustained and significant improvements in sleep onset and maintenance, and also improved next-day concentration and morning sleepiness in people with insomnia.

The study focused on 1,018 patients between 18 and 64 years of age with chronic primary insomnia, who had difficulty initiating or maintaining sleep or experiencing non-restorative sleep for three months or greater. The subjects took either a single dose of zolpidem extended-release or a placebo from three to seven nights per week.

According to the results, there was a statistically significantly greater benefit in the zolpidem group than in the placebo group on patient global ratings of improvement, with no reduction in clinical efficacy over the course of the study and no evidence of rebound insomnia upon drug discontinuation. At the 12-week end point, 89.7 percent of zolpidem extended-release patients reported that the medication helped them sleep, compared with 51.4 percent of placebo patients.

"Approximately 10 percent of the population suffers from chronic insomnia. These individuals are most commonly treated with medications in clinical practice, though for many years we lacked data on the long-term medication management of insomnia, said Andrew D. Krystal, MD, of Duke University, lead author of the study. However, recent studies document the efficacy and safety of nightly treatment with some insomnia agents for periods of up to one year. As the duration of treatment increases, the costs and risks of adverse effects associated with taking a medication nightly become increasingly important considerations. For the chronic insomnia patients who have waxing and waning symptom severity, it may be possible to decrease the costs and risks by employing non-nightly medication dosi
'/>"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. News briefs from the journal Chest, August 2007
2. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
3. Elsevier launches new journal: Stem Cell Research
4. Elsevier announces new journal on inflammatory bowel diseases
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
7. Good Clinical Practice Journal Awards: Winners Announced
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
10. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
11. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...earch in sexual adaptation shows that evidence is ...on. According to a review appearing in Current Di...havioral sexual characteristics exhibited by human...to deliver their sperm more effectively to females...
...-targeted therapy and hormonal therapy may be the ...an effective treatment for ovarian cancer, accord...f Gynecological Cancer. Several clinical trials h...erapy in recurrent ovarian cancer treatment, espec...
...ider, a cousin to the well-known black widow, is i...y . It is belongs to a group that is officially k...ly referred to as "fiddleback" spiders or "violin"...ng on the top surface of the cephalothorax (fused ...
... its efforts to prevent the spread of drug-resista...available in the public health sector and providin...ocial Development Zola Skweyiya said at a media br... In addition, Skweyiya said that the country is ex...
Other Medicine News:Health News:Louisiana Residents Warned Against Brown Recluse Spiders 2Health News:South Africa Increasing Efforts To Contain Drug-Resistant TB, Minister Says 2
(Date:8/18/2008)... JERUSALEM, Israel, August 18 /PRNewswire-FirstCa...B) ( http://www.oramed.com ), a developer,of oral ...t, entitled "Open,Label Study to Assess the Safety...of Five Oral Insulin Formulations in Healthy,Subje...ming 44th Annual,Meeting of the European Associati...
(Date:8/18/2008)... BETHESDA, Md., Aug. 18 /-...cal company developing novel, proprietary,antibodi...utoimmune,diseases, will host a webcast and confer...t 10:00 a.m. Eastern Time (4:00 p.m. Central Europ...re published in the Journal,SCIENCE on August 15, ...
(Date:8/14/2008)... A Complimentary Continuing Education ... Cytomegalovirus (CMV) is a,significant cause of m...tic,stem cell transplantation. The clinical manife... gastrointestinal disease to life-threatening,pneu...is., In order to prevent CMV infection and reduce...
(Date:8/14/2008)...bit,s HybSelect(TM) Technology Evaluated to Enable... Next-Generation-Sequencing, LEXINGTON, Mass. and...t,and the Translational Genomics Research Institut...oration in which TGen will evaluate,Next-Generatio...,proprietary Geniom(R) Microarray Technology., fe...
Breaking Medicine Technology:Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance 2febit and TGen Collaborate to Study New DNA Capture Method 2febit and TGen Collaborate to Study New DNA Capture Method 3AmeriCares Purchases BLU MED Portable Hospital for China Earthquake Relief 21366 1AmeriCares Purchases BLU MED Portable Hospital for China Earthquake Relief 21366 2Diabetes Drug May Slow Eye Disease 21363 1Diabetes Drug May Slow Eye Disease 21363 2Phase 3 results for alogliptin 21359 1Phase 3 results for alogliptin 21359 2Phase 3 results for alogliptin 21359 3UNICEF 26 Merck Partner to Protect 100 000 Children and Young People Against Mumps Epidemic 21355 1UNICEF 26 Merck Partner to Protect 100 000 Children and Young People Against Mumps Epidemic 21355 2UNICEF 26 Merck Partner to Protect 100 000 Children and Young People Against Mumps Epidemic 21355 3
...--(BUSINESS WIRE)--May 29, 2007 - Panacos,Pharmace...ny,dedicated to developing the next generation of ...e results of a new study,indicating that HIV resis...potential for the development of resistance to the...assays. The study,carried out by scientists in Dr...
...SS WIRE)--May 29, 2007 - Mitopharm Corporation,In...esearch paper,where Professor Dr. Robert Ko publis...recursor of (-) Schisandrin B - a novel,discovery ...rch paper entitled "SCHISANDRIN B PROTECTS AGAINST...NG MYOCARDIAL,GLUTATHIONE ANTIOXIDANT STATUS"; Yim...
Other Medicine Technology:Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 2Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 3Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 2Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 3
...ra with networking capability for viewing high res...ge acquisition and camera manipulation is fast and...es directly to a LAN/WAN. No PC or special softwar... images in real time is possible. Displays and cap...
The AxioCam from Carl Zeiss developed for the microscopist by the microscopy expert. Not only does it generate needle-sharp, color-fast images in all image formats, it is also optimally adjusted to
...s a new standard for high-quality digital photomic...rom the highly successful DP11 Digital Camera, the...hanging demands. CCD - 1/1.8 inch interlace sca...al 1/4000 sec. - 8 sec. Live Image Display - 30...
Bench Top Horizontal (clean bench) Airflow Cabinet
Medicine Products: